| pubmed-article:20800803 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20800803 | lifeskim:mentions | umls-concept:C0034065 | lld:lifeskim |
| pubmed-article:20800803 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:20800803 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:20800803 | lifeskim:mentions | umls-concept:C0175630 | lld:lifeskim |
| pubmed-article:20800803 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:20800803 | pubmed:issue | 6-7 | lld:pubmed |
| pubmed-article:20800803 | pubmed:dateCreated | 2010-8-30 | lld:pubmed |
| pubmed-article:20800803 | pubmed:abstractText | Flow cytometry has shown levels of platelet-derived microparticles (PMPs) and endothelial-derived microparticles (EMPs) to be elevated in deep-vein thrombosis. Cardiovascular risk factors can also contribute to hypercoagulability due to circulating procoagulant microparticles (CPMPs). | lld:pubmed |
| pubmed-article:20800803 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20800803 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20800803 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20800803 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20800803 | pubmed:issn | 1875-2128 | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:TedguiAlainA | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:FreyssinetJea... | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:MallatZiadZ | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:BoccaraFranck... | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:CohenArielA | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:TotiFlorenceF | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:BalLaurenceL | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:ZobairiFatiha... | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:MeulemanCathe... | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:EderhyStéphan... | lld:pubmed |
| pubmed-article:20800803 | pubmed:author | pubmed-author:DufaitreGhisl... | lld:pubmed |
| pubmed-article:20800803 | pubmed:copyrightInfo | Copyright 2010. Published by Elsevier Masson SAS. | lld:pubmed |
| pubmed-article:20800803 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20800803 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:20800803 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20800803 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20800803 | pubmed:pagination | 394-403 | lld:pubmed |
| pubmed-article:20800803 | pubmed:dateRevised | 2011-4-25 | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:meshHeading | pubmed-meshheading:20800803... | lld:pubmed |
| pubmed-article:20800803 | pubmed:articleTitle | Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. | lld:pubmed |
| pubmed-article:20800803 | pubmed:affiliation | Cardiology Department, Saint-Antoine University and Medical School, Assistance Publique-Hôpitaux de Paris, université Pierre-et-Marie-Curie, 75571 Paris cedex 12, France. | lld:pubmed |
| pubmed-article:20800803 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20800803 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
